Cite
HARVARD Citation
Iland, H. et al. (2015). Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial. Lancet. 2 (9), pp. e357-e366. [Online].